Early and accurate diagnosis of Alzheimer's disease (AD) has a major impact on the progress of research on dementia. To address the problems involved in diagnosing AD in its earliest stages, the National Institute on Aging, the American Association of Retired Persons, the National Institute of Neurological and Communicative Disorders and Stroke, and the National Institute of Mental Health jointly sponsored a workshop for planning research. The purpose of the meeting was to identify the most important scientific research opportunities and the crucial clinical and technical issues that influence the progress of research on the diagnosis of AD. The 37 participants included some of the most knowledgeable and eminent scientists and physicians actively involved in the study of AD. The participants were divided among six panels representing the disciplines of neurochemistry, neuropathology, neuroradiology, neurology, neuropsychology, and psychiatry. Within each of the panels, participants discussed specific areas of research requiring further
[1]
A. P. Richardson.
CONGO RED: ABSORPTION, DISTRIBUTION AND SOJOURN IN BLOOD
,
1939
.
[2]
A. P. Richardson.
CONGO RED: HEMATOLOGIC ACTIONS
,
1939
.
[3]
CONGO RED: TOXICITY AND SYSTEMIC ACTIONS
,
1939
.
[4]
M. Yahr,et al.
Autopsy findings in parkinsonism following treatment with levodopa
,
1972,
Neurology.
[5]
M. Folstein,et al.
The use of life tables and survival analysis in testing genetic hypotheses, with an application to Alzheimer's disease.
,
1983,
American journal of epidemiology.
[6]
M. Folstein,et al.
Familial Alzheimer Dementia: a prevalent disorder with specific clinical features
,
1984,
Psychological Medicine.
[7]
D. Kupfer,et al.
Elevated red blood cell/plasma choline ratio in dimentia of the Alzheimer type: Clinical and polysomnographic correlates
,
1984,
Psychiatry Research.